Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Giant Biogene Holding Co. Ltd. ( (HK:2367) ) has provided an announcement.
Giant Biogene Holding Co., Ltd announced that its controlling shareholder, Juzi Holding Co., Ltd, has increased its shareholding by purchasing 1,150,000 shares, amounting to approximately HK$62.9 million. This move reflects Juzi Holding’s strong confidence in the company’s future development and aims to promote sustainable growth and stability.
The most recent analyst rating on (HK:2367) stock is a Hold with a HK$58.00 price target. To see the full list of analyst forecasts on Giant Biogene Holding Co. Ltd. stock, see the HK:2367 Stock Forecast page.
More about Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd is a company incorporated in the Cayman Islands, primarily involved in the biotechnology sector. The company focuses on sustainable and stable development, with a commitment to safeguarding the interests of public investors.
Average Trading Volume: 11,770,014
Technical Sentiment Signal: Buy
Current Market Cap: HK$57.21B
See more insights into 2367 stock on TipRanks’ Stock Analysis page.